Shandong Xinhua Pharmaceutical Company Limited Class H (0719) Income Statement

2 Followers

Shandong Xinhua Pharmaceutical Company Limited Class H Income Statement

Last quarter (Q4 2025), Shandong Xinhua Pharmaceutical Company Limited Class H's total revenue was ¥1.96B, an increase of 13.31% from the same quarter last year. In Q4, Shandong Xinhua Pharmaceutical Company Limited Class H's net income was ¥33.17M. See Shandong Xinhua Pharmaceutical Company Limited Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	¥ 8.52B	¥ 8.47B	¥ 8.10B	¥ 7.50B	¥ 6.56B
Gross Profit	¥ 1.59B	¥ 2.04B	¥ 2.32B	¥ 2.04B	¥ 1.77B
Operating Expenses	¥ 1.25B	¥ 1.51B	¥ 1.79B	¥ 1.49B	¥ 1.27B
Depreciation and Amortization	¥ 0.00	¥ 540.95M	¥ 516.94M	¥ 484.81M	¥ 434.33M
EBITDA	¥ 337.37M	¥ 1.11B	¥ 1.09B	¥ 1.01B	¥ 908.67M
Operating Income	¥ 337.37M	¥ 534.37M	¥ 534.58M	¥ 476.71M	¥ 425.59M
Other Income/Expenses	¥ 12.25M	¥ -717.25K	¥ -1.90M	¥ -4.93M	¥ -4.36M
Pretax Income	¥ 349.63M	¥ 533.65M	¥ 532.69M	¥ 471.77M	¥ 421.23M
Net Income	¥ 282.39M	¥ 470.02M	¥ 496.51M	¥ 411.06M	¥ 348.55M
Per Share Metrics
Basic EPS	¥ 0.41	¥ 0.69	¥ 0.72	¥ 0.62	¥ 0.56
Diluted EPS	¥ 0.40	¥ 0.69	¥ 0.72	¥ 0.61	¥ 0.56
Weighted Average Shares Outstanding	689.51M	682.41M	689.60M	663.22M	622.41M
Weighted Average Shares Outstanding (Diluted)	691.62M	682.41M	691.95M	674.09M	622.41M

Currency in CNY

Shandong Xinhua Pharmaceutical Company Limited Class H (0719) Income Statement

Shandong Xinhua Pharmaceutical Company Limited Class H Income Statement

Shandong Xinhua Pharmaceutical Company Limited Class H Earnings and Revenue History